Keywords: Pfizer, Lyrica, Japan approval, Eisai, Neuropathic pain

Japanese regulator approves Pfizer's Lyrica for peripheral neuropathic pain

Article | 01 November 2010

Print This

The Japanese Ministry of Health, Labor and Welfare approved US drug behemoth Pfizer’s (NYSE: PFE) Lyrica (pregabalin) capsules ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in